136 related articles for article (PubMed ID: 28856214)
21. Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Glander P; Braun KP; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer HH; Budde K
Clin Biochem; 2001 Oct; 34(7):543-9. PubMed ID: 11738390
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of ABX Pentra DX 120 and Sysmex XE-2100 in umbilical cord blood.
Kim H; Hur M; Choi SG; Kim BH; Moon HW; Yun YM; Hwang HS; Kwon HS; Sohn IS
Int J Lab Hematol; 2013 Dec; 35(6):658-65. PubMed ID: 23738834
[TBL] [Abstract][Full Text] [Related]
23. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Kuhn J; Götting C; Kleesiek K
Talanta; 2010 Mar; 80(5):1894-8. PubMed ID: 20152429
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine.
Hibino S; Nagai T; Yamakawa S; Ito H; Tanaka K; Uemura O
Clin Exp Nephrol; 2017 Feb; 21(1):152-158. PubMed ID: 27105859
[TBL] [Abstract][Full Text] [Related]
25. The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney tissue.
Alsmadi MM; Alfarah MQ; Albderat J; Alsalaita G; AlMardini R; Hamadi S; Al-Ghazawi A; Abu-Duhair O; Idkaidek N
Biopharm Drug Dispos; 2019 Nov; 40(9):325-340. PubMed ID: 31674040
[TBL] [Abstract][Full Text] [Related]
26. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
27. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
[TBL] [Abstract][Full Text] [Related]
28. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
[TBL] [Abstract][Full Text] [Related]
29. Optimization of laboratory workflow in clinical hematology laboratory with reduced manual slide review: comparison between Sysmex XE-2100 and ABX Pentra DX120.
Hur M; Cho JH; Kim H; Hong MH; Moon HW; Yun YM; Kim JQ
Int J Lab Hematol; 2011 Aug; 33(4):434-40. PubMed ID: 21418541
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
[TBL] [Abstract][Full Text] [Related]
31. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
32. Nephrotic state substantially enhances apparent mycophenolic acid clearance
.
Kirpalani A; Rothfels L; Sharma AP; Cuellar CR; Filler G
Clin Nephrol; 2019 Mar; 91(3):162-171. PubMed ID: 30574862
[TBL] [Abstract][Full Text] [Related]
33. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a novel quantitative canine species-specific point-of-care assay for C-reactive protein.
Hindenberg S; Keßler M; Zielinsky S; Langenstein J; Moritz A; Bauer N
BMC Vet Res; 2018 Mar; 14(1):99. PubMed ID: 29554960
[TBL] [Abstract][Full Text] [Related]
35. Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients.
Kikuchi M; Tanaka M; Takasaki S; Takahashi A; Akiba M; Matsuda Y; Noda M; Hisamichi K; Yamaguchi H; Okada Y; Mano N
J Pharm Health Care Sci; 2018; 4():7. PubMed ID: 29619240
[TBL] [Abstract][Full Text] [Related]
36. Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.
Saint-Marcoux F; Guigonis V; Decramer S; Gandia P; Ranchin B; Parant F; Bessenay L; Libert F; Harambat J; Bouchet S; Broux F; Compagnon P; Marquet P
Pharmacol Res; 2011 May; 63(5):423-31. PubMed ID: 21272643
[TBL] [Abstract][Full Text] [Related]
37. Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC.
Carlucci F; Anzini M; Rovini M; Cattaneo D; Merlini S; Tabucchi A
Electrophoresis; 2007 Nov; 28(21):3908-14. PubMed ID: 17922503
[TBL] [Abstract][Full Text] [Related]
38. Automated determination of blood metabolic acidosis, total acid phosphatase, angiotensin converting enzyme, fructosamine and urinary oxalate and citrate on the ABX Pentra 400.
Boularan AM; Dupuy AM; Cristol JP
Clin Lab; 2007; 53(7-8):461-7. PubMed ID: 17821952
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.
Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model.
Langman LJ; Shapiro AM; Lakey JR; LeGatt DF; Kneteman NM; Yatscoff RW
Transplantation; 1996 Jan; 61(1):87-92. PubMed ID: 8560580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
